Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inhibitors of IL-5 production disclosed in patent literature by Janssen

July 5, 2000

New compounds from Banyu block M3 receptors, prove effective in canine model of bronchoconstriction

July 5, 2000

Idec and Taisho to develop antibodies targeting inflammatory and autoimmune diseases

July 5, 2000

Potential new treatments for asthma from Roche act as chemokine receptor antagonists

July 4, 2000

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

July 4, 2000

AWD-12-343 compares favorably with known PDE4 inhibitors in model of lung inflammation

June 30, 2000

Selective PDE4 inhibitors with bronchodilating, antiinflammatory properties

June 29, 2000

United Therapeutics discontinues UT-77 development project

June 28, 2000

Use of seratrodast for COPD supported by clinical results

June 28, 2000

Roche presents 4-aroylpiperidines active as chemokine receptor antagonists

June 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...